Identification of SYK inhibitor, R406 as a novel senolytic agent-Reference-Cited by-同舟云学术

Identification of SYK inhibitor, R406 as a novel senolytic agent

Published:2020-05-07 Issue:9 Volume:12 Page:8221-8240
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Cho Hyun-Ji¹²,Yang Eun Jae³,Park Joon Tae⁴,Kim Jae-Ryong⁵,Kim Eok-Cheon⁵,Jung Kyong-Jin⁵,Park Sang Chul¹⁶⁷,Lee Young-Sam¹³

Affiliation:

1. Well Aging Research Center, DGIST, Daegu 42988, Korea

2. Department of Medicine, Catholic University of Daegu School of Medicine, Daegu 42472, Korea

3. Department of New Biology, DGIST, Daegu 42988, Korea

4. Division of Life Sciences, College of Life Sciences and Bioengineering, Incheon National University, Incheon 22012, Korea

5. Department of Biochemistry and Molecular Biology, Smart-Aging Convergence Research Center, College of Medicine, Yeungnam University, Daegu 42415, Korea

6. Department of Molecular Medicine, Chonnam National University Medical School, Gwangju 58128, Korea

7. The Future Life and Society Research Center, Chonnam National University, Gwangju 58128, Korea

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular senescence: A novel therapeutic target for central nervous system diseases;Biomedicine & Pharmacotherapy;2024-10

2. Cellular senescence and SASP in tumor progression and therapeutic opportunities;Molecular Cancer;2024-08-31

3. Polygenic prediction of human longevity on the supposition of pervasive pleiotropy;Scientific Reports;2024-08-28

4. A novel natural Syk inhibitor suppresses IgE-mediated mast cell activation and passive cutaneous anaphylaxis;Bioorganic Chemistry;2024-05

5. Current senolytics: Mode of action, efficacy and limitations, and their future;Mechanisms of Ageing and Development;2024-02